Shares in Australian biotechnology giant CSL Limited (ASX: CSL) are on the move today amid a heating battle between the company and the US Border Patrol.

At the time of writing, CSL shares are changing hands at $304.61 apiece, which is just under a 2% gain from the open.

CSL has filed an injunction against the US Customs and Border Protection agency after the latter instated new rules governing the mobility of Mexican citizens into the US to donate plasma earlier in the year.

Here we cover the central points of the debate between the two parties.

What has led us to this point?

In June, the US Customers and Border Protection agency declared that certain visa holders are ineligible to donate plasma if they receive payment for doing so.

The agency claims that donating plasma in this fashion is akin to ‘labour for hire’ and is therefore prohibited for individuals on B-1 and/or B-2 visas – the particular category in question.

CSL has since fired back, teaming up with Spanish pharmaceuticals manufacturer Grifols SA (BME: GRF) in filing an injunction against the agency, effectively for interrupting the biotech’s ongoing business.

From its annual earnings report, plasma collection and separation accounted for roughly 85% of CSL’s earnings in FY21, well ahead of its vaccines and antivenom segments.

Furthermore, the industry is reliant on Mexican nationals entering the US to make plasma donations, with some estimates stating this accounts for 5–10% of all global plasma collections.

It, therefore, stands to reason that any impact to this flow of blood plasma collection could pose a material threat to CSL’s earnings potential, as it also relies heavily on plasma as a raw ingredient to construct its unique formulations.

In its defence, the US agency responded by stating there has never been a policy in situ that governs the mobility of Mexican citizens into and out of the US to donate plasma.

And even though CSL argues that receiving payment after donating plasma signifies ‘international business activity’ rather than the performance of labour, the US agency thinks otherwise.

It reckons that because the transactions take place only in the US, they cannot be considered an international business activity, which is a defining feature of the visas in question.

Nonetheless, CSL is of the firm belief that an ongoing shutdown to its plasma collection in this route could be detrimental to its business, hence why it has filed the lawsuit alongside Grifols.

The biotech’s CEO Paul Perreault was quoted as saying that “It is a bold move, but you know I don’t mind putting my neck out when patients are waiting” in the company’s annual report last month.

As the injunction was heard only last week or so, investors are still awaiting the outcome of any decision from US authorities regarding the matter.

CSL share price snapshot

It’s been a difficult year for CSL and its share price this year, having posted a gain of just 7.5% since January 1.

Over the past 12 months, it has climbed around 6%, a step in behind the benchmark S&P/ASX 200 index (ASX: XJO)’s return of around 25% in that time.

The post CSL (ASX:CSL) share price lifts 2% amid US Border Patrol battle appeared first on The Motley Fool Australia.

More reading

• Own CSL shares? Here’s how the company actually makes money
• Top ASX shares to buy in November 2021
• CSL (ASX:CSL) share price history: The major highlights (and low points)
• What Goldman Sachs is saying about the CSL (ASX:CSL) share price after its R&D update
• The CSL (ASX:CSL) share price is up just 3% so far in 2021. Here’s why

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3nJN9TA

The Telstra Corporation Ltd (ASX: TLS) share price has started the week on a positive note.

At the time of writing, the telco giant’s shares are up 1.5% to $3.88.

This latest gain means Telstra’s shares are now up approximately 29% in 2021.

Can the Telstra share price keep rising?

The good news for investors is that it may not be too late to buy the telco’s shares.

This is because one leading broker still sees plenty of upside for the Telstra share price over the next 12 months.

A recent note out of Morgans reveals that its analysts have retained their add rating and lifted their price target on the company’s shares to $4.55.

Based on the current Telstra share price, this implies potential upside of 17% for investors before dividends. This increases to just over 21% if you include the 16 cents per share dividend Morgans is forecasting in FY 2022.

Four reasons Telstra could be a buy

Morgans is positive on the Telstra share price for four key reasons.

The first, it explained, is: “Industry dynamics have turned positive (NBN and mobile prices are increasing after 5 years of decline; TLS’s targets imply they continue to rise).”

“The SOTP [sum of the parts] for TLS is worth more than the current share price (and steps to release this value are underway; albeit timing is unclear),” Morgans reveals as another reason.

The broker is also positive on the recent deal with the Federal Government to acquire the Digicel Pacific business.

It commented: “While PNG is not without risk, this deal shows management’s ability to sensibly manage risk, and it could create further upside, all going to plan.”

The final reason Morgans is bullish on the Telstra share price is its growth outlook. After years of earnings declines, the broker notes that Telstra is well-placed for growth in the coming years.

“Underlying earnings returned to growth in 2H21 and should continue growing out to FY25,” it concluded.

All in all, this could make Telstra worth considering in November.

The post 4 reasons the Telstra (ASX:TLS) share price could be in the buy zone appeared first on The Motley Fool Australia.

More reading

• Brokers rate these 2 ASX dividend shares as top buys today
• These 3 ASX 200 shares are topping the volume charts on Friday
• 2 top ASX dividend shares with 4%+ yields
• These 3 ASX 200 shares are topping the volume charts this Thursday
• Telstra (ASX:TLS) share price struggles amid energy deal news

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Corporation Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3jTtShl

As a long-term investor, it is incredibly important to see companies, such as CSL Limited (ASX: CSL), and its shares, as more than flickering ticker codes with an erratic dollar value. Instead, these listed entities are collections of people with a shared mission.

Part of what makes a company valuable is its mission and what it does to work towards that goal. That being said, it can be easy to lose sight of what a company does that provides shareholders with a return. Even for a company with the stature of CSL, Australia’s second-largest listed company by market capitalisation, understanding the money-making business activity can be lost in the pile of information.

For this reason, we’ll be diving into how CSL shares actually earn their keep in the present day.

How does CSL make money?

Although CSL isn’t quite a ‘household’ name, its products have touched the lives of many people. The company’s roots stem all the way from 1916 when it was known as Commonwealth Serum Laboratories, an Australian government-owned entity involved in vaccine manufacture.

While its history is extensive and incredibly interesting, spattered with a long list of monumental breakthroughs in modern medicine, we are here to cover how the CSL we know today makes money.

The publically-listed and privatised version of CSL that Aussies invest in these days has two distinct business operations. These two businesses include CSL Behring and Seqirus.

Firstly, CSL Behring is a provider of medicines to treat people with rare and serious diseases. These treatments are across multiple areas of immunology, haematology, cardiovascular, and transplant therapeutics. In terms of how much money the Behring business ‘Beh-rings’ in, it is more than 80% of the company’s US$10.3 billion of annual revenue. This is derived through the sale of its broad range of products including tetanus shots, coagulants, etc. to more than 100 countries.

Secondly, the Seqirus side of CSL’s operations is focused on influenza vaccines. In fact, Seqirus is one of the leading providers of ‘flu shots in the world. However, investors in CSL shares mightn’t know it manufactures a unique range of products made in the national interest. These products include antivenoms and Q fever vaccines.

In FY21, Seqirus pulled in total revenue of $1.736 billion, an increase of 30% year on year. This was due to the strong demand for CSL’s influenza vaccines to reduce strain on hospitals during COVID-19.

How have CSL shares performed?

The CSL share price has been a solid performer over long time periods. For example, in the last five years, the CSL share price has gained 208%. This represents a compound annual growth rate (CAGR) of 25.28%, which far outpaces the S&P/ASX 200 Index (ASX: XJO) CAGR of 7.22% in the last five years.

However, CSL returns have been more modest over the past 12 months. In the last year, the CSL share price has climbed 6.18% higher, significantly lower than its historical performance.

The post Own CSL shares? Here’s how the company actually makes money appeared first on The Motley Fool Australia.

More reading

• Top ASX shares to buy in November 2021
• CSL (ASX:CSL) share price history: The major highlights (and low points)
• What Goldman Sachs is saying about the CSL (ASX:CSL) share price after its R&D update
• The CSL (ASX:CSL) share price is up just 3% so far in 2021. Here’s why
• ASX 200 (ASX:XJO) midday update: BHP’s Q1 update, CSL’S R&D update

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/2ZCOOC7

The Westpac Banking Corp (ASX: WBC) share price has come under significant pressure on Monday.

In morning trade, the banking giant’s shares are down over 6% to $24.10.

Why is the Westpac share price sinking?

Investors have been selling down the Westpac share price today after its full year results fell short of expectations.

In case you missed it, Australia’s oldest bank reported a 138% increase in statutory net profit to $5,458 million and a 105% jump in cash earnings to $5,352 million. This allowed Westpac to declare a fully franked final dividend of 60 cents per share and announce a $3.5 billion off-market share buyback.

However, despite its cash earnings doubling in FY 2021, it was still short of the consensus estimate of $5.42 billion.

What else?

Also falling short of expectations and weighing on the Westpac share price was its off-market share buyback. While Westpac announced a significant $3.5 billion buyback, it was lower than the market was forecasting.

The team at Morgans, for example, were expecting Westpac to announce a buyback of $5 billion with its results, whereas Goldman Sachs was forecasting a $4 billion share buyback.

Goldman also notes that the bank’s expenses and net interest margin (NIM) were disappointing.

It commented: “WBC’s 2H21 NIM was down 10 bp hoh to 1.99% (1.98% ex notables) and was lower than our expectations (GSe, -6 bp to 2.03%).”

“On outlook, WBC notes that FY22 Margins are expected to be lower and highlighted exit margin ex. treasury & markets at 1.80% (1.87% Sep-21 half average),” the broker added.

As for expenses, Goldman said: “WBC 2H21 reported expenses were up 22% hoh, 5% higher than GSe. Excluding notable items, 2H21 expenses were up 9% hoh. WBC attributes most of the increase to higher staff expenses (+18%, +14% ex notables) due to the additional 1,396 FTE over the half on higher resourcing needs to improve risk management and compliance and to support customers impacted by hardship.”

All in all, a disappointing result from the banking giant.

One positive, though, is that the Westpac share price is still up 23% in 2021 despite today’s weakness.

The post Westpac (ASX:WBC) share price sinks 6% despite doubling cash earnings appeared first on The Motley Fool Australia.

More reading

• Westpac (ASX:WBC) share price on watch amid earnings jump and $3.5bn buyback
• 5 things to watch on the ASX 200 on Monday
• Could the Westpac (ASX:WBC) share price be about to take off?
• This big bank ASX share is ready to break out
• Westpac (ASX: WBC) share price rises as it announces changes to its board

Motley Fool contributor James Mickleboro owns shares of Westpac Banking Corporation. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3pTWhI3

Ausnet Services Ltd (ASX: AST) share price has jumped in early trade as the company agrees to terms set out in an offer from Brookfield Asset Management to acquire all of its outstanding shares.

Ausnet confirmed the offer values its shares at $2.65 each, a step up from Brookfield’s previous offer of $2.50 around a month ago.

At the time of writing, Ausnet shares are trading for $2.57 apiece, up 4.05% on their opening price.

What did Ausnet announce today?

Ausnet’s announcement notes that it agreed to the terms set out in Brookfield’s proposal and has subsequently entered into a scheme implementation deed.

Brookfield is representing a consortium of investors including Sunsuper Superannuation Fund, Alberta Investment Management Corporation, and two large institutional investors from Ontario, Canada.

Back in September, Brookfield first made its proposal when it offered $2.50 per Ausnet share to acquire the company. At the time, this represented a 26% premium to Ausnet’s share price of $1.98.

The revised offer now puts Brookfield at an enterprise value of $17.8 billion, equating to $2.65 per share for its available equity.

As such, the offer is roughly a 7% premium to Ausnet’s closing price on Friday and a 34% bump on when it first received the offer on 20 September.

As an additional sweetener, if the scheme is implemented after March next year, Ausnet shareholders will get “an additional consideration from Brookfield of $0.000260274 per share for each day after 31 March 2022” that it is not implemented.

One large Ausnet shareholder, Singapore Power – which owns 32.74% of Ausnet’s shares – is in support of the proposal and intends to vote in favour, according to the announcement.

Curiously, one caveat in Brookfield’s offer is that Ausnet must cease all discussions with all other competing parties.

Consequently, it has terminated its due diligence process with APA Group (ASX: APA) after APA had offered a cash and scrip deal on a valuation of $2.60 per Ausnet share in a competing bid last month.

Although, Ausnet did state that “if APA wishes to make a further proposal, (it is) free to do so, as is any other party”.

The company needs to tread carefully, however, as it will be “required to pay Brookfield a break fee of $101,674,267 (or 1% of its equity value) if the Ausnet board ultimately recommends a competing, superior proposal”.

Speaking on the announcement, Ausnet chair Peter Mason said:

For the last several weeks the Board has been extremely focused on ensuring a competitive process. This has resulted in a binding proposal from Brookfield at a price that provides full value to all AusNet shareholders. The binding proposal, secured at a significant premium to where the share price was trading prior to the first of the six proposals being received, deserves to be put before our shareholders for their consideration.

What’s next for the Ausnet share price?

Shareholders can expect to receive the scheme booklet before the end of March 2022 when they will vote on the scheme.

Given that Singapore Power and its board have already pushed to approve, many are curious to see the outcome from the company’s remaining shareholders.

It’s been a year of outsized returns for Ausnet after the onset of this acquisition saga. The Ausnet share price has gained 41% since January 1, extending its return in the last 12 months to 23.5%.

The post Ausnet (ASX:AST) share price jumps as Brookfield offers $2.65/share appeared first on The Motley Fool Australia.

More reading

• Here are the 3 heaviest trading ASX 200 shares so far this Thursday

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3mw5QdV

The IGO Ltd (ASX: IGO) share price is on the move on Monday morning.

At the time of writing, the battery materials focused mining company’s shares are up 4% to $10.03.

Why is the IGO share price storming higher?

Investors have been bidding the IGO share price higher this morning following the release of its first quarter update.

For the three months ended 30 September, IGO’s Nova production was within guidance, with nickel, copper, and cobalt production of 6,889 tonnes, 3,023 tonnes, and 253 tonnes, respectively. In addition, Nova’s cash costs of $1.99 per payable pound was better than guided to.

In respect to its financials, IGO’s sales revenue was 29% lower quarter on quarter to $189.2 million. This was driven by the divestment of the Tropicana Gold Operation on 31 May 2021.

It was a similar story on the bottom line, with IGO’s net profit after tax falling 90% quarter on quarter to $46 million. This was due to the previous quarter including a post-tax gain on the sale of the Tropicana Operation of $385 million.

At the end of the period, IGO’s total cash stood at $552 million. This is an increase of $24 million since the end of June and does not include its undrawn debt facilities of $450 million.

Management commentary

IGO’s Managing Director and CEO, Peter Bradford, commented: “We are pleased to have commenced FY22 strongly with a solid quarter of safe performance from Nova. In parallel, good progress was achieved within the lithium joint venture, with key growth projects being advanced during the first reporting period following the successful completion of IGO’s investment in the lithium joint venture with Tianqi Lithium Corporation.”

“At the Greenbushes Lithium Mine, Chemical Grade Plant 2 has been commissioned, Tailings Retreatment Plant construction activity was progressed with commissioning expected in early 2022, and the EPCM contract for the design and engineering for Chemical Grade Plant 3 was awarded to Lycopodium Limited.”

“At the Kwinana Refinery commissioning of Train 1 has been progressed with a key milestone achieved during August with the first lithium hydroxide produced,” he added.

Mr Bradford notes that the above developments come at a time when lithium demand is increasing strongly, driving prices higher. This could bode well for the company’s future and the IGO share price in 2022.

The IGO share price is now up 49% in 2021.

The post IGO (ASX:IGO) share price storms higher on Q1 update appeared first on The Motley Fool Australia.

More reading

• Top brokers name 3 ASX shares to buy today
• IGO (ASX:IGO) share price soars 4% on nickel-copper update
• IGO (ASX:IGO) share price lifts after exploration update
• The Pilbara Minerals (ASX:PLS) share price surges on resource upgrade

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/2ZCKLFV

The Macquarie Group Ltd (ASX: MQG) share price has returned from its trading halt and is dropping.

In early trade, the investment bank’s shares are down 2.5% to $193.26.

Why was the Macquarie share price halted?

The Macquarie share price was placed in a trading halt last week so it could undertake a $1.5 billion institutional placement following its half year update.

Macquarie’s Group Chief Executive Officer, Shemara Wikramanayake, explained: “Having deployed $5.5 billion of capital over 2H21 and 1H22, we continue to see a strong pipeline of opportunities. Raising new capital provides us with additional flexibility to invest in new opportunities where the expected risk-adjusted returns are attractive to our shareholders, while maintaining an appropriate capital surplus.”

This morning the Macquarie share price has returned to trade after announcing the successful completion of the placement.

According to the release, the placement was conducted by way of a bookbuild and will result in the issue of 7.7 million new fully paid ordinary shares at a price of $194.00 per new share. This represents a discount of just 1.9% to the Macquarie share price prior to its halt.

Ms Wikramanayake commented: “We are very pleased with the success of the Placement and the strong signal of support delivered from Australian and international institutional shareholders. Macquarie remains committed to investing in the growth of our businesses in a disciplined manner.”

A share purchase plan will soon follow, providing shareholders with the opportunity to apply for up to $30,000 of shares. This will be offered at the lower of the placement price (adjusted for the interim dividend) or a 2% volume weighted average price during the five days prior to the closing date of the share purchase plan.

Half year results impress

It’s not often that a capital raising is undertaken at such a small discount to a company’s current share price.

However, Macquarie was able to achieve this after impressing the market with its half year result.

For the six months ended 30 September, the investment bank reported a first half net profit of $2,043 million. This was double what it recorded in the prior corresponding period and in line with the second half of FY 2021. This allowed the Macquarie Board to declare a partially franked interim dividend of $2.72 per share.

The result went down well with the team at Citi. This morning it upgraded the investment bank’s shares to a buy rating with a $226.00 price target.

Despite today’s decline, the Macquarie share price is still up almost 40% in 2021.

The post Macquarie (ASX:MQG) share price falls after completing $1.5bn capital raising appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Monday
• ASX 200 (ASX:XJO) midday update: Macquarie doubles profit, ResMed jumps
• Macquarie (ASX:MQG) doubles half year profit and launches $1.5bn capital raising
• The ASX 200 share I’d hold for 5 years: fund manager
• Macquarie (ASX:MQG) share price booted from $200 club after only one day

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3BwmONM

Due to a disappointing finish to the month, the S&P/ASX 200 Index (ASX: XJO) recorded a small monthly decline in October and finished the period at 7,323.7 points.

While a good number of shares dropped with the market, some fell more than most. Here’s why these were the worst performing ASX 200 shares last month:

Whitehaven Coal Ltd (ASX: WHC)

The Whitehaven Coal share price was the worst performer on the ASX 200 last month with a decline of 22.3%. Investors were selling the coal miner’s shares amid a pullback in coal prices during the month. This follows reports in China that coal producers in the country have agreed to observe a price ceiling for thermal coal ahead of the winter heating season.

EML Payments Ltd (ASX: EML)

The EML Payments share price wasn’t far behind with a disappointing 21.3% decline during the month. Investors were selling the payments company’s shares following the release of an update on regulatory action by the Central Bank of Ireland (CBI). The CBI revealed that it is planning to take action against EML’s PFS Card Services (Ireland) business. While no financial details have been provided by EML, management warned that the potential directions “could materially impact the European operations of the Prepaid Financial Services (PFS) business.”

Codan Limited (ASX: CDA)

The Codan share price was out of form and sank 19.3% in October. All of this decline came in the final week of the month following the release of the technology company’s annual general meeting update. Investors appear to have been concerned with comments regarding its softer growth outlook. Management also highlighted that COVID-19 tailwinds contributed $15 million to $20 million of sales in FY 2021. These tailwinds are unlikely to be repeated in FY 2022.

Pendal Group Ltd (ASX: PDL)

The Pendal share price was a poor performer and tumbled 17.4% over the period. Investors were selling the fund manager’s shares following the release of its latest funds under management (FUM) update. For the September quarter, Pendal reported a large increase in its FUM. However, this increase was driven by a recent acquisition. Excluding this, Pendal reported net fund outflows of $2.3 billion during the three months.

The post These were the worst performing ASX 200 shares in October appeared first on The Motley Fool Australia.

More reading

• These were the best performing ASX 200 shares in October
• 5 things to watch on the ASX 200 on Monday
• Here’s why the Bank of Queensland (ASX:BOQ) share price tumbled 5% in October
• These were the worst performing ASX 200 shares last week
• These were the best performing ASX 200 shares last week

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended EML Payments and Netwealth. The Motley Fool Australia owns shares of and has recommended EML Payments and Netwealth. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/2ZFFugt

A disappointing end to the month led to the S&P/ASX 200 Index (ASX: XJO) finishing the period with the smallest of monthly declines at 7,323.7 points.

The good news is that this didn’t stop a number of shares from charging higher in October. Here’s why these were the best performing ASX 200 shares last month:

Perenti Global Ltd (ASX: PRN)

The Perenti share price was the best performer on the ASX 200 last month with a 23.6% gain. This appears to have been driven by a positive reaction to the mining services company’s annual general meeting. At the meeting management retained its guidance and spoke positively about the future, noting that investments have been made to support its sustainable growth. In response to the meeting, Macquarie retained its outperform rating and lifted its price target to $1.10.

Netwealth Group Ltd (ASX: NWL)

The Netwealth share price wasn’t far behind with a gain of 22.7% during the month. Investors were fighting to buy the investment platform provider’s shares in October after the release of a strong first quarter update. Netwealth reported record first quarter net inflows of $4 billion, which took its funds under administration (FUA) to $52 billion. In response, Ord Minnett retained its buy rating and lifted its price target to $19.50.

Silver Lake Resources Limited (ASX: SLR)

The Silver Lake Resources share price was on form and charged 21.9% higher over the period. This appears to have been driven by a strong quarterly update by the gold miner. Silver Lake reported record quarterly gold production of 31,033 ounces at its Deflector operation. This took its group quarterly gold production to 64,947 ounces. In light of this, management believes it is well-positioned to deliver its FY 2022 group gold sales guidance of 235,000–255,000 ounces.

GUD Holdings Limited (ASX: GUD)

The GUD share price was a strong performer and rose 21.4% in October. There were a couple of catalysts for this strong gain. One was the release of a trading update at the Citi Australia & NZ Investment Conference. GUD revealed that demand for its products has remained resilient despite widespread and protracted lockdowns. As a result, GUD’s revenue and EBIT are currently tracking in line with management’s expectations. In addition, late on in the month, the company announced an agreement to acquire specialist lighting company Vision-X for US$53 million.

The post These were the best performing ASX 200 shares in October appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Monday
• Here’s why the Bank of Queensland (ASX:BOQ) share price tumbled 5% in October
• These were the worst performing ASX 200 shares last week
• These were the best performing ASX 200 shares last week
• These 3 ASX 200 shares are topping the volume charts on Friday

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Netwealth. The Motley Fool Australia owns shares of and has recommended Netwealth. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3btCLcS

The Washington H. Soul Pattinson and Co. Ltd (ASX: SOL) (Soul Patts) share price may be one worth considering for a few different reasons.

This investment conglomerate is one of the oldest businesses on the ASX, having been around for almost 120 years.

Its historical performance shows outperformance of the index over the last five, ten and twenty years.

But there could be good reasons to continue to think about this business:

Lower price

A lower price can be an attractive thing when considering to buy shares of a business. A cheaper price doesn’t always mean better value, however if the underlying business has not changed then that could signal that it’s an opportunity.

Over the last month the Soul Patts share price has fallen by almost 15%.

It may be worth keeping in mind that there is an underlying portfolio value of Soul Patts because of all of its investments in businesses like TPG Telecom Ltd (ASX: TPG), Brickworks Limited (ASX: BKW) and New Hope Corporation Limited (ASX: NHC). That particular trio of companies are investments that Soul Patts has held for many years when they were much smaller businesses.

Increasing diversification

Soul Patts is working on becoming an even more diversified business with continuing growth potential.

The investment conglomerate aims to have a portfolio of assets which generate reliable cashflow through market cycles which serves to protect downside in market corrections.

It also looks to invest for the long-term with a disciplined and value-focused approach to investing through market cycles to deliver returns.

Soul Patts’ investment style allows it to invest in and support companies from an early stage and grow with them over the long-term. It can invest in various asset classes such as listed equities, private equity, venture capital, property, structure credit and cash.

The business has been investing in new areas in recent years. The investment conglomerate has been investing in agriculture and luxury retirement living.

However, after the recent acquisition of the listed investment company (LIC) Milton, it is now looking at other areas. The Milton CEO and managing director has become the new chief investment officer of Soul Patts. Mr Brendan O’Dea has had a number of roles, including being the chief operating officer of Citigroup’s Pan Asian Equities, head of Japanese equities and head of US equity proprietary investments.

Soul Patts outlined it is looking to build around platforms for growth. Some of the key thematics that it’s looking at includes education, financial services, agriculture, energy transition and health and ageing. The investment conglomerate noted the sell down of some of Milton’s large cap shares will be used for private markets, global shares, property, ‘structured yield’ and ‘real assets’.

Dividend record

One of the key objectives of Soul Patts is to deliver a consistent growing dividend. It has been successful with this goal for over 20 years. The company is the only one in the All Ordinaries Index to have achieved this growth record.

Soul Patts believes that the merger with Milton will allow for higher cash generation from increased portfolio dividends.

In FY21, it continued its dividend growth streak with an increase of the total dividend by a further 3.3%.

At the current Soul Patts share price, it has a grossed-up dividend yield of 2.7%.

The post 3 reasons why the Soul Patts (ASX:SOL) share price could be a buy appeared first on The Motley Fool Australia.

More reading

• 2 ASX dividend shares that could be buys in November 2021
• Why has the Soul Patts (ASX:SOL) share price tumbled 16% in a month?
• Soul Pattinson (ASX:SOL) share price wobbles as company touts track record
• Can the Brickworks (ASX:BKW) share price hit $30 by Christmas?
• Own Brickworks (ASX:BKW) shares? Here’s what you’re invested in

Motley Fool contributor Tristan Harrison owns shares of Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Brickworks. The Motley Fool Australia owns shares of and has recommended Brickworks and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has recommended TPG Telecom Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/2ZGEKrL